Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2022-06-07 2022-06-07
Drug Identification Number 02242146 02242146
Brand name SALOFALK SALOFALK
Common or Proper name mesalamine suppository mesalamine suppository
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients MESALAZINE MESALAZINE
Strength(s) 1G 1G
Dosage form(s) SUPPOSITORY SUPPOSITORY
Route of administration RECTAL RECTAL RECTAL RECTAL
Packaging size 30s 30s
ATC code A07EC A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-05-25 2022-05-25
Actual start date
Estimated end date 2022-06-08 2022-06-08
Actual end date 2022-06-06 2022-06-06
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments